Junjie Peng

4.5k total citations · 1 hit paper
87 papers, 2.6k citations indexed

About

Junjie Peng is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Junjie Peng has authored 87 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 22 papers in Surgery. Recurrent topics in Junjie Peng's work include Colorectal Cancer Treatments and Studies (25 papers), Colorectal Cancer Surgical Treatments (22 papers) and Genetic factors in colorectal cancer (21 papers). Junjie Peng is often cited by papers focused on Colorectal Cancer Treatments and Studies (25 papers), Colorectal Cancer Surgical Treatments (22 papers) and Genetic factors in colorectal cancer (21 papers). Junjie Peng collaborates with scholars based in China, United States and Australia. Junjie Peng's co-authors include Sanjun Cai, Ye Xu, Dan Huang, Renyuan Gao, Yuji Toiyama, Cheng Pan, Mingming Yin, Ping Wang, Minfeng Liu and Bomin Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Junjie Peng

84 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21

2016 761 citations Junjie Peng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junjie Peng China	26	1.3k	991	569	503	360	87	2.6k
Jean-Michel Vignaud France	32	828 0.7×	935 0.9×	561 1.0×	526 1.0×	909 2.5×	87	2.9k
Yasushi Kojima Japan	27	1.0k 0.8×	766 0.8×	340 0.6×	605 1.2×	458 1.3×	133	2.6k
Koji Okabayashi Japan	31	1.2k 1.0×	760 0.8×	293 0.5×	1.2k 2.3×	532 1.5×	177	3.0k
Myoung Hee Kang South Korea	25	857 0.7×	885 0.9×	337 0.6×	261 0.5×	322 0.9×	63	2.1k
Alfredo Ribeiro‐Silva Brazil	26	890 0.7×	658 0.7×	444 0.8×	341 0.7×	225 0.6×	124	2.1k
Norikatsu Miyoshi Japan	28	1.1k 0.9×	1.9k 1.9×	738 1.3×	821 1.6×	568 1.6×	202	3.6k
Koji Miyanishi Japan	32	1.0k 0.8×	1.5k 1.5×	449 0.8×	823 1.6×	582 1.6×	151	4.0k
Jussi M. Halleen Finland	34	1.7k 1.4×	2.2k 2.2×	225 0.4×	373 0.7×	318 0.9×	86	4.1k
Seung‐Hyun Jung South Korea	30	454 0.4×	1.1k 1.1×	628 1.1×	407 0.8×	285 0.8×	153	2.8k

Countries citing papers authored by Junjie Peng

Since Specialization

Citations

This map shows the geographic impact of Junjie Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Peng more than expected).

Fields of papers citing papers by Junjie Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Peng. The network helps show where Junjie Peng may publish in the future.

Co-authorship network of co-authors of Junjie Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Peng. A scholar is included among the top collaborators of Junjie Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Peng. Junjie Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Junjie, Jiannong Cao, Yang Ou, et al.. (2025). Effectiveness of virtual reality technology in rehabilitation after anterior cruciate ligament reconstruction: A systematic review and meta-analysis. PLoS ONE. 20(3). e0314766–e0314766. 3 indexed citations

Wang, Feng, Junjie Peng, Xinjun Liang, et al.. (2024). First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study.. Journal of Clinical Oncology. 42(16_suppl). 3569–3569. 2 indexed citations

Peng, Junjie, et al.. (2023). Prevalence and related factors of cognitive frailty in diabetic patients in China: a systematic review and meta-analysis. Frontiers in Public Health. 11. 1249422–1249422. 7 indexed citations

He, Xingfeng, Yan Jiang, Long Zhang, et al.. (2023). Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer. Frontiers in Bioengineering and Biotechnology. 11. 1190637–1190637. 29 indexed citations

Yang, Mei, et al.. (2023). Association between chronic obstructive pulmonary disease and periodontal disease: a systematic review and meta-analysis. BMJ Open. 13(6). e067432–e067432. 4 indexed citations

Shi, Xiangjun, et al.. (2023). Two new nilotinib polymorphs with solubility advantages prepared by the melt crystallization process. Journal of Drug Delivery Science and Technology. 84. 104511–104511. 10 indexed citations

Chen, Gong, Junjie Peng, Qian Xiao, et al.. (2021). Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer. Journal of Hematology & Oncology. 14(1). 80–80. 107 indexed citations

Fu, Guoxiang, Liping Liang, Xiaomeng Li, et al.. (2020). SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival. Cancer Letters. 501. 20–30. 32 indexed citations

Mo, Shaobo, Xiaoji Ma, Yaqi Li, et al.. (2020). Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000881–e000881. 29 indexed citations

10.

He, Yiping, Xiaoji Ma, Ke Chen, et al.. (2020). <p>Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis</p>. Cancer Management and Research. Volume 12. 1621–1630. 23 indexed citations

11.

Liu, Min, Tongyu Sun, Ni Li, et al.. (2019). BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration. Nature Communications. 10(1). 4614–4614. 77 indexed citations

12.

Hu, Xiang, Yaqi Li, Xiaoji Ma, et al.. (2019). A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy. Frontiers in Oncology. 9. 704–704. 11 indexed citations

13.

Feng, Yang, Yaqi Li, Dan Huang, Sanjun Cai, & Junjie Peng. (2018). HER2 as a potential biomarker guiding adjuvant chemotherapy in stage II colorectal cancer. European Journal of Surgical Oncology. 45(2). 167–173. 12 indexed citations

14.

Zhuo, Changhua, Lei Liang, Mingang Ying, et al.. (2015). Laparoscopic Low Anterior Resection and Eversion Technique Combined With a Nondog Ear Anastomosis for Mid- and Distal Rectal Neoplasms. Medicine. 94(50). e2285–e2285. 15 indexed citations

15.

Shi, Debing, Hongtu Zheng, Changhua Zhuo, et al.. (2014). Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer. Medical Oncology. 31(7). 31–31. 71 indexed citations

16.

Peng, Junjie, Xinxiang Li, Ying Ding, et al.. (2013). Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?. Radiation Oncology. 8(1). 290–290. 2 indexed citations

17.

Lu, Yuanming, et al.. (2012). Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Cancer Biomarkers. 11(5). 219–226. 35 indexed citations

18.

Peng, Junjie, et al.. (2010). Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Disease. 13(2). e14–e19. 40 indexed citations

19.

Cai, Guoxiang, Ye Xu, Xiaoli Zhu, et al.. (2009). A Simple Scoring System Based on Clinical Features to Predict Locally Advanced Rectal Cancers. Journal of Gastrointestinal Surgery. 13(7). 1299–1305. 5 indexed citations

20.

Peng, Junjie, Ye Xu, Ji Zhu, et al.. (2008). Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer. Annals of Surgical Oncology. 15(11). 3118–3123. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact